Portal del Investigador
Infliximab in inflammatory bowel disease. Is premedication necessary?
Abstract
Background: The use of infliximab (IFX) in inflammatory bowel disease (IBD) has been associated with a 1-6% risk of infusion reactions. The usefulness of premedication with corticosteroids, paracetamol and /or antihistamines is controversial.
Más información
| Título según WOS: | Infliximab in inflammatory bowel disease. Is premedication necessary? |
| Título de la Revista: | GASTROENTEROLOGIA Y HEPATOLOGIA |
| Volumen: | 44 |
| Número: | 5 |
| Editorial: | Barcelona |
| Fecha de publicación: | 2021 |
| Página de inicio: | 321 |
| Página final: | 329 |
| DOI: |
10.1016/J.GASTROHEP.2020.07.018 |
| Notas: | ISI |